Gregory Oakes - Net Worth and Insider Trading

Gregory Oakes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Oakes owns 2 companies in total, including Entero Therapeutics Inc (ENTO) , and Landos Biopharma Inc (LABP) .

Click here to see the complete history of Gregory Oakes’s form 4 insider trades.

Insider Ownership Summary of Gregory Oakes

Ticker	Comapny	Transaction Date	Type of Owner
ENTO	Entero Therapeutics Inc	2022-01-03	director
LABP	Landos Biopharma Inc	2022-06-20	director & Chief Executive Officer

Gregory Oakes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory Oakes Ownership Network

Ownership Network List of Gregory Oakes

No Data

Ownership Network Relation of Gregory Oakes

Gregory Oakes Owned Company Details

What does Entero Therapeutics Inc do?

Who are the key executives at Entero Therapeutics Inc?

Gregory Oakes is the director of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include Chief Financial Officer Sarah Romano , director & President and CEO James Sapirstein , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .

Entero Therapeutics Inc (ENTO) Insider Trades Summary

Over the past 18 months, Gregory Oakes made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 4,066 shares made by Sarah Romano , a net sale of 6,280 shares made by James Sapirstein , and a net sale of 6,063 shares made by Charles J Casamento .

In summary, during the past 3 months, insiders sold 476 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 476 shares. During the past 18 months, 6,431 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,431 shares.

Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entero Therapeutics Inc Insider Transactions

No Available Data

Gregory Oakes Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Oakes. You might contact Gregory Oakes via mailing address: 760 Parkside Avenue, Suite 304, Brooklyn Ny 11226.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.